InsidersTradesSigma
Track the 塩野義製薬株式会社 stock price and the full insider trade history of the company, a publicly traded company based in Japan. Shares trade on JP JP, under the authority of EDINET (Japan FSA). Operating in the Banks sector, 塩野義製薬株式会社 has recorded 6 public disclosures. Market capitalisation: €40,416.3bn. The latest transaction was disclosed on 19 September 2025 (Holding update). Among the most active insiders: Sumitomo Mitsui Trust Bank,Limited. The full history is openly available.
Analysts rate 塩野義製薬株式会社 Buy (bullish), based on 11 analysts. Average price target: JP¥3,596.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
Shionogi & Co., Ltd. is a Japanese pharmaceutical company focused on the research and development of medications. It is listed on the Tokyo Stock Exchange under the symbol XTKS.